Our science & research

Scientific overviewOur research

Science & Research

Scientific overview

Rhythm’s unique focus is on rare melanocortin-4 receptor (MC4R) pathway diseases. These are characterised by hyperphagia (insatiable hunger) and severe obesity.

Many factors influence the balance of energy intake (food consumption) and energy expenditure (metabolic rate, thermogenesis, and physical activity). While many environmental factors can influence this balance, our genes also play a significant role.

Research has shown that some naturally arising genetic variants are associated with hyperphagia (insatiable hunger) and severe obesity. However, it’s important to note that the impact of these variants on body weight can vary considerably.1-3

The MC4R pathway can be impaired by such genetic variants and is at the centre of our efforts to transform the care of those living with rare MC4R pathway diseases.4,5

The MC4R pathway

MC4R pathway

The MC4R pathway is a critical regulator of hunger and energy balance. It affects body weight by controlling food intake and energy expenditure.1

Leptin

The pathway involves the hormone leptin which is produced by adipose (fat) tissue. In the hypothalamus, a key part of the brain that helps regulate hunger, leptin activates the MC4R pathway causing a cascade of chemical changes that reduce appetite and increase energy expenditure.1,3

Energy imbalance

When signalling in the MC4R pathway becomes impaired, energy balance can become disrupted and lead to hyperphagia (insatiable hunger) and severe obesity.1,3

Rare MC4R pathway diseases

Rare MC4R pathway diseases generally arise because of the following:5-7

Rare, highly impactful variants in just one gene that result in loss of function in the MC4R pathway

Rare, highly impactful variants in different families of genes that lead to diseases such as Alström syndrome, and Bardet-Biedl syndrome

An acquired injury to the hypothalamic region resulting in impairment to the MC4R pathway. This leads to hypothalamic obesity

Hyperphagia

One of the cardinal symptoms of rare MC4R pathway diseases is hyperphagia (insatiable hunger) that leads to excess energy intake contributing to obesity.3

Hyperphagia (insatiable hunger) can be characterised by the following:8

An overwhelming, heightened, and relentless hunger

A longer time to reach satiety (feeling full)

A shorter duration of satiety

Extreme food-seeking behaviours such as waking up at night to find food or sneaking food

If you are a patient, caregiver or member of the public based outside of the US who would like to find out more, please visit:

Patient Website

If you are a healthcare professional based outside of the US who would like to find more, please visit:

Path4HCPs

References

 
  • 1. Fonseca ACP, et al., J Diabetes Complications. 2017;31(10):1549-1561
  • 2. Littleton H., et al., Mol Diagn Ther. 2020;24(6):653-663
  • 3. Yazdi F, et al. Peer J. 2015;3:e856
  • 4. Kühnen P., et al., Cell Press Review. 2018; 25: 136-148
  • 5. Huvenne H, et al., Obes Facts. 2016; 9(3):158-173
  • 6. Haqq AM, et al., Lanc Diab & Endo. 2022 ; 10(12) :859-868
  • 7. Kim JH, Choi JH. Annals of Pediatric End. 2013;(18):161-167
  • 8. Heymsfield SB, et al. H. Obesity (Silver Spring). 2014